Modulation of 5-fluorouracil in the adjuvant setting: high-dose, low-dose or no-dose leucovorin?
Taal
Barbara G
BG
Department of Gastroenterology and Hepatology, Netherlands Cancer Institute, Amsterdam, The Netherlands. b.taal@nki.nl
Cats
Annemieke
A
van Tinteren
Harm
H